Copertina

Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Xiaozhi Liao, Timothy Qi, Jiawei Zhou, Can Liu, Yanguang Cao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
di: Mohamed Elmeliegy, et al.
Pubblicazione: (2024)

Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
di: Ting Wang, et al.
Pubblicazione: (2025)

Quantitative Lesion‐Level Modeling Reveals Organ‐Dependent Therapeutic Response
di: Ian Dilley, et al.
Pubblicazione: (2026)

Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
di: KyoungSoo Lim, et al.
Pubblicazione: (2024)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
di: Prathap Nagaraja Shastri, et al.
Pubblicazione: (2024)

The Future of Clinical Translational Pharmacology
di: Matthew L. Rizk, et al.
Pubblicazione: (2026)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
di: Sonya Tang Girdwood, et al.
Pubblicazione: (2025)

Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making
di: Linh M. Van, et al.
Pubblicazione: (2025)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Pubblicazione: (2025)

Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases
di: Susana Neves‐Zaph, et al.
Pubblicazione: (2024)

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
di: Georgi I. Kapitanov, et al.
Pubblicazione: (2025)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
di: Chanchala Kaddi, et al.
Pubblicazione: (2024)

Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
di: Miramar Sami Kardouh, et al.
Pubblicazione: (2025)

History and Evolution of Innovations in Clinical Pharmacology
di: Lawrence J. Lesko, et al.
Pubblicazione: (2025)

American Society for Clinical Pharmacology and Therapeutics
Pubblicazione: (2026)

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
di: Qi Liu, et al.
Pubblicazione: (2024)

Progress in Clinical Pharmacology in China: An Ongoing Evolution
di: Liang Zhao, et al.
Pubblicazione: (2025)

Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
di: Wei Gao, et al.
Pubblicazione: (2025)

Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies
di: Hardik Mody, et al.
Pubblicazione: (2024)

From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
di: Karen Rowland Yeo, et al.
Pubblicazione: (2026)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
di: Aaron S. Devanathan, et al.
Pubblicazione: (2025)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
di: Yow‐Ming C. Wang, et al.
Pubblicazione: (2024)

New Horizons for Clinical Pharmacology & Therapeutics : Global Outreach for Optimal Patient Outcomes
di: Karen Rowland Yeo
Pubblicazione: (2025)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
di: Robin DiFrancesco, et al.
Pubblicazione: (2026)

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
di: Karthik Venkatakrishnan, et al.
Pubblicazione: (2025)

Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine
di: Iris K. Minichmayr, et al.
Pubblicazione: (2024)

Tocilizumab Dosing for Management of T Cell‐Engaging Bispecific Antibody‐Related CRS in Patients With R/R B‐Cell NHL
di: Candice Jamois, et al.
Pubblicazione: (2025)

Modeling Supports Combinatorial Effects Between Pharmacological and Non‐Pharmacological Interventions to Prevent Opioid‐Induced Cardiac Arrest
di: Bradlee Thrasher, et al.
Pubblicazione: (2026)

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
di: John D. Davis, et al.
Pubblicazione: (2024)

HIV Pharmacology Data Repository: Setting the New Information‐Sharing Standard for Clinical and Preclinical Pharmacokinetic Studies
di: Lauren A.R. Tompkins, et al.
Pubblicazione: (2025)

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
di: Liang Zhao, et al.
Pubblicazione: (2024)

Leading the Way: Multi‐Drug Resistance Protein (MDR1) and Clinical Pharmacology—Commentary on Kim et al.
di: Kathleen M. Giacomini
Pubblicazione: (2025)

A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology
di: Huy X. Ngo, et al.
Pubblicazione: (2024)

Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL‐1: Clinical Pharmacology Results
di: Jue Gong, et al.
Pubblicazione: (2025)

Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
di: Sara Belli, et al.
Pubblicazione: (2024)

Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost
di: Vaishali Sahasrabudhe, et al.
Pubblicazione: (2025)

Extracellular Vesicles as Immunotherapeutic Mediators in Gastrointestinal Cancers and Diseases: From Mechanisms to Clinical Translation
di: Xiaona Lin, et al.
Pubblicazione: (2026)

The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics‐Based Clinical Guidelines
di: Janine Scholefield, et al.
Pubblicazione: (2026)

Ongoing Pharmacological Developments in SLC6A1 Research & Treatment
di: Melissa B. DeLeeuw, et al.
Pubblicazione: (2024)

Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model‐Based Evaluation of Important Pharmacological Attributes
di: Anik Chaturbedi, et al.
Pubblicazione: (2025)